Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > Press > Tumor study reveals size limitations for new drugs: Normalizing tumor blood vessels improves delivery of only the smallest nanomedicines

Top panels: control setups. Bottom panels: Mammary tumor tissue after normalization of blood vessels. Left: Few of the large nanoparticles are visible. Right: The smaller nanoparticles have penetrated well. Courtesy of Vikash Chauhan / Nature Nanotech.
Top panels: control setups. Bottom panels: Mammary tumor tissue after normalization of blood vessels. Left: Few of the large nanoparticles are visible. Right: The smaller nanoparticles have penetrated well.

Courtesy of Vikash Chauhan / Nature Nanotech.

Abstract:
Combining two strategies that are designed to improve the results of cancer treatment—angiogenesis inhibitors and nanomedicines—may only be successful if the smallest nanomedicines are used.

Tumor study reveals size limitations for new drugs: Normalizing tumor blood vessels improves delivery of only the smallest nanomedicines

Cambridge, MA | Posted on April 10th, 2012

A new study led by researchers at the Harvard School of Engineering and Applied Sciences (SEAS) and Massachusetts General Hospital (MGH) has found that normalizing blood vessels within tumors, which improves the delivery of standard chemotherapy drugs, can actually block the delivery of larger nanotherapy molecules.

"We found that vascular normalization only increases the delivery of the smallest nanomedicines to cancer cells," says lead author Vikash P. Chauhan, a graduate student in bioengineering at SEAS. "We also showed that the smallest nanomedicines are inherently better than larger nanomedicines at penetrating tumors, suggesting that smaller nanomedicines may be ideal for cancer therapy."

The results have been published in Nature Nanotechnology.

Angiogenesis, the tumor-driven creation of new blood vessels, provides growing cancers with a food source—but it also provides a potential channel for drug delivery.

The problem is that the vessels supplying tumors tend to be disorganized, oversized, and leaky. These abnormalities prevent the delivery of chemotherapy drugs to cells that are not close to the tumor vessels. The leakage of plasma out of blood vessels also increases pressure within the tumor, further reducing the drugs' ability to penetrate the tissue. Fortunately, drugs that inhibit angiogenesis can reduce some of these problems in a process called vascular normalization.

"Anti-angiogenic agents are prescribed to a large number of cancer patients in combination with conventional therapeutics," explains principal investigator Rakesh K. Jain, Cook Professor of Radiation Oncology (Tumor Biology) at Harvard Medical School and director of the Steele Laboratory of Tumor Biology at MGH. Jain is also Chauhan's Ph.D. adviser.

The combination of standard chemotherapy drugs and normalization therapy has previously been shown to improve the effectiveness of treatment on some types of cancer.

New nanomedicines, on the other hand, are designed to exploit the abnormality of tumor vessels. Nanomedicines, despite the name, are actually about 10 to 100 times larger than standard chemotherapy drugs—too large to penetrate the pores of blood vessels in normal tissues, but still small enough to pass through the oversized pores of tumor vessels. Because nanomedicines generally cannot penetrate normal tissues, they are expected to cause fewer side effects.

The question in the Harvard-MGH study was whether vascular normalization would help or hinder the delivery of nanomedicines to tumors. The researchers found, through both theory and in vivo experimentation, that it depends on the size of the nanomedicines.

Their mathematical model predicted that inhibiting angiogenesis would simultaneously reduce the size of the pores in the blood vessels and relieve pressure in the tumor, allowing small particles to penetrate.

Confirming this experimentally in a mouse model of breast cancer, the investigators showed that vascular normalization (using an antibody called DC101) improved the penetration of 12-nanometer particles but not of 60- or 125-nanometer particles.

They treated mice with implanted breast tumors either with DC101 and Doxil, a 100-nanometer version of the chemotherapy drug doxorubicin, or with DC101 and Abraxane, a 10-nanometer version of paclitaxel. Although treatment with both chemotherapeutics delayed tumor growth, vascular normalization with DC101 improved the effectiveness only of Abraxane and had no effect on Doxil treatment.

"A variety of anticancer nanomedicines are currently in use or in clinical trials," says Chauhan, who completed the work at MGH. "Our findings suggest that combining smaller nanomedicines with anti-angiogenic therapies may have a synergistic effect and that smaller nanomedicines should inherently penetrate tumors faster than larger nanomedicines, due to the physical principles that govern drug penetration. While it looks like future development of nanomedicines should focus on making them small—around 12 nanometers in size—we also need to investigate ways to improve delivery of the larger nanomedicines that are currently in use."

Additional co-authors of the Nature Nanotechnology report are Triantafyllos Stylianopoulos, John Martin, Walid Kamoun, and Dai Fukumura of MGH; and Zoran Popovic, Ou Chen, and Moungi Bawendi of Massachusetts Institute of Technology (MIT).

The work benefited from a long-term collaboration between Harvard, MGH, and MIT that explores the use of quantum dots as a biocompatible fluorescent marker in medical studies.

Support for the study included grants from the National Institutes of Health and the Department of Defense.

####

For more information, please click here

Contacts:
Caroline Perry
(617) 496-1351

Copyright © Harvard's School of Engineering and Applied Sciences (SEAS)

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

New class of protein misfolding simulated in high definition: Evidence for recently identified and long-lasting type of protein misfolding bolstered by atomic-scale simulations and new experiments August 8th, 2025

Sensors innovations for smart lithium-based batteries: advancements, opportunities, and potential challenges August 8th, 2025

Deciphering local microstrain-induced optimization of asymmetric Fe single atomic sites for efficient oxygen reduction August 8th, 2025

Lab to industry: InSe wafer-scale breakthrough for future electronics August 8th, 2025

Imaging

ICFO researchers overcome long-standing bottleneck in single photon detection with twisted 2D materials August 8th, 2025

Simple algorithm paired with standard imaging tool could predict failure in lithium metal batteries August 8th, 2025

First real-time observation of two-dimensional melting process: Researchers at Mainz University unveil new insights into magnetic vortex structures August 8th, 2025

Govt.-Legislation/Regulation/Funding/Policy

New imaging approach transforms study of bacterial biofilms August 8th, 2025

INRS and ELI deepen strategic partnership to train the next generation in laser science:PhD students will benefit from international mobility and privileged access to cutting-edge infrastructure June 6th, 2025

Electrifying results shed light on graphene foam as a potential material for lab grown cartilage June 6th, 2025

Institute for Nanoscience hosts annual proposal planning meeting May 16th, 2025

Nanomedicine

New molecular technology targets tumors and simultaneously silences two ‘undruggable’ cancer genes August 8th, 2025

New imaging approach transforms study of bacterial biofilms August 8th, 2025

Cambridge chemists discover simple way to build bigger molecules – one carbon at a time June 6th, 2025

Electrifying results shed light on graphene foam as a potential material for lab grown cartilage June 6th, 2025

Discoveries

Deciphering local microstrain-induced optimization of asymmetric Fe single atomic sites for efficient oxygen reduction August 8th, 2025

ICFO researchers overcome long-standing bottleneck in single photon detection with twisted 2D materials August 8th, 2025

New molecular technology targets tumors and simultaneously silences two ‘undruggable’ cancer genes August 8th, 2025

Simple algorithm paired with standard imaging tool could predict failure in lithium metal batteries August 8th, 2025

Announcements

Sensors innovations for smart lithium-based batteries: advancements, opportunities, and potential challenges August 8th, 2025

Deciphering local microstrain-induced optimization of asymmetric Fe single atomic sites for efficient oxygen reduction August 8th, 2025

Japan launches fully domestically produced quantum computer: Expo visitors to experience quantum computing firsthand August 8th, 2025

ICFO researchers overcome long-standing bottleneck in single photon detection with twisted 2D materials August 8th, 2025

Military

Quantum engineers ‘squeeze’ laser frequency combs to make more sensitive gas sensors January 17th, 2025

Chainmail-like material could be the future of armor: First 2D mechanically interlocked polymer exhibits exceptional flexibility and strength January 17th, 2025

Single atoms show their true color July 5th, 2024

NRL charters Navy’s quantum inertial navigation path to reduce drift April 5th, 2024

Quantum Dots/Rods

A new kind of magnetism November 17th, 2023

IOP Publishing celebrates World Quantum Day with the announcement of a special quantum collection and the winners of two prestigious quantum awards April 14th, 2023

Qubits on strong stimulants: Researchers find ways to improve the storage time of quantum information in a spin rich material January 27th, 2023

NIST’s grid of quantum islands could reveal secrets for powerful technologies November 18th, 2022

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project